Galmed Pharmaceuticals Ltd. (GLMD)

NASDAQ: GLMD · IEX Real-Time Price · USD

0.379

+0.022 (6.05%)

At close: Apr 18, 2024, 4:00 PM

0.400

+0.021 (5.62%)

Pre-market: Apr 19, 2024, 4:08 AM EDT

Galmed Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2012
Net Income	-6.91	-17.87	-32.47	-28.77	-20.46	-9.86	-12.3	-16.95	-10.62	-9.1	Upgrade
Depreciation & Amortization	0.03	0.04	0.04	0.04	0.04	0.39	0.24	0.17	0.05	0.01	Upgrade
Share-Based Compensation	0.89	1.3	1.89	2.07	2.23	1.78	1.39	1.63	0.97	0.6	Upgrade
Other Operating Activities	-0.15	-1.97	-2.35	0.38	3.26	-1.34	-1.4	3.03	1.13	-0.75	Upgrade
Operating Cash Flow	-6.14	-18.5	-32.89	-26.29	-14.94	-9.02	-12.07	-12.13	-8.47	-9.24	Upgrade
Capital Expenditures	0	-0	-0.01	-0.04	-0.01	-0.09	-0.01	-0	-0.16	-0.77	Upgrade
Acquisitions	-1.5	0	0	0	0	0	0	0	0	0	Upgrade
Change in Investments	2.3	17.57	11.47	16.58	6.69	-59.93	6.46	6.34	-10.95	-8.25	Upgrade
Other Investing Activities	-	-	-0	-	-	-	-	-	-	-	Upgrade
Investing Cash Flow	0.8	17.56	11.46	16.54	6.68	-60.02	6.44	6.34	-11.11	-9.02	Upgrade
Share Issuance / Repurchase	6.19	0.07	17.37	0.77	0.14	80.18	15.55	4.73	0	41.86	Upgrade
Financing Cash Flow	6.19	0.07	17.37	0.77	0.14	80.18	15.55	4.73	0	41.86	Upgrade
Net Cash Flow	0.85	-0.87	-4.06	-8.98	-8.12	11.14	9.92	-1.06	-19.58	23.6	Upgrade
Free Cash Flow	-6.14	-18.51	-32.9	-26.33	-14.95	-9.11	-12.08	-12.13	-8.63	-10.01	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-447.15%	-1113.27%	-2598.07%	-	-	Upgrade
Free Cash Flow Per Share	-2.22	-11.04	-20.07	-18.56	-10.62	-7.54	-14.51	-16.00	-11.67	-14.55	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).